GSK Urges Del. Judge To Enhance $235M Skinny Label Win

By Dani Kass · January 28, 2025, 9:27 PM EST

GlaxoSmithKline LLC is urging a Delaware federal judge to enhance the $235 million damages award a jury issued against Teva Pharmaceuticals USA Inc. in 2017, now that the dispute over skinny...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Case Information

Case Title

GlaxoSmithKline LLC et al v. Teva Pharmaceuticals USA Inc.

Case Number

Court

Delaware

Nature of Suit

Patent

Date Filed

July 03, 2014

Recent Articles By Dani

January 13, 2025
Supreme Court Turns Away IP Safe Harbor Dispute
January 01, 2025
Patent Cases To Watch In 2025
December 20, 2024
Sens. Aim To Protect Generics With Skinny Labels In New Bill
December 18, 2024
Patent Limits For Biosimilar Litigation Lands In Spending Bill
December 18, 2024
Amgen Hit With $50M Infringement Verdict Over Leukemia Drug
December 04, 2024
Fed. Circ. Judge Condemns 'Nonsense' Law In Antibody Fight
December 03, 2024
USPTO Abandons Polarizing Proposal Over Double Patenting
December 03, 2024
Vidal Aimed To Put USPTO Rulemaking In The Spotlight
November 06, 2024
How The Patent System May Look After Trump's Return
October 17, 2024
Justices Urged To Fix 'Novel Misreading' Of IP Safe Harbor